Yukihide Iwamoto Selected Research

Yukihide Iwamoto Research Topics

Disease

78	Neoplasms (Cancer) 09/2020 - 01/2002
34	Osteonecrosis (Kienbock's Disease) 01/2018 - 06/2002
29	Sarcoma (Soft Tissue Sarcoma) 11/2022 - 10/2003
20	Rheumatoid Arthritis 07/2017 - 02/2002
13	Synovial Sarcoma (Synovioma) 01/2022 - 04/2002
13	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2005
13	Pain (Aches) 05/2020 - 02/2002
12	Osteoarthritis 01/2017 - 03/2003
10	Osteosarcoma (Osteogenic Sarcoma) 03/2020 - 02/2003
9	Stress Fractures (Stress Fracture) 01/2022 - 04/2005
9	Chondrosarcoma 10/2019 - 07/2006
9	Congenital Abnormalities (Deformity) 03/2017 - 01/2003
8	Spinal Cord Injuries (Spinal Cord Injury) 03/2017 - 11/2005
8	Arthritis (Polyarthritis) 12/2015 - 01/2002
7	Leiomyosarcoma 01/2018 - 10/2004
7	Inflammation (Inflammations) 08/2015 - 06/2003
6	Infections 09/2020 - 12/2002
6	Liposarcoma 02/2020 - 09/2002
6	Neurofibrosarcoma (MPNST) 01/2018 - 05/2005
6	Rhabdoid Tumor (Rhabdoid Tumors) 10/2016 - 06/2006
6	Ewing Sarcoma (Sarcoma, Ewing) 08/2015 - 01/2002
6	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2011 - 01/2002
5	Carcinogenesis 01/2018 - 01/2006
4	Wounds and Injuries (Trauma) 01/2022 - 07/2010
4	Giant Cell Tumor of Bone 06/2021 - 01/2004
4	Contracture 05/2020 - 08/2002
4	Aggressive Fibromatosis (Desmoid) 05/2020 - 01/2002
4	Testicular Neoplasms (Testicular Cancer) 01/2018 - 07/2015
4	Hip Dislocation 05/2017 - 10/2014
4	Genetic Translocation (Chromosomal Translocation) 07/2012 - 05/2004
3	Femoral Fractures (Femoral Fracture) 08/2016 - 05/2003
3	Rhabdomyosarcoma 04/2016 - 04/2008
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2015 - 06/2002
3	Myxoid Liposarcoma 07/2015 - 12/2005
3	Scoliosis 04/2014 - 01/2011
3	Bone Resorption 11/2013 - 06/2003
3	Leukocytosis (Pleocytosis) 06/2012 - 07/2006
3	Chordoma 04/2009 - 01/2005
3	Breast Neoplasms (Breast Cancer) 04/2008 - 02/2003
2	Spontaneous Fractures (Pathological Fracture) 01/2022 - 07/2010
2	Fibrosis (Cirrhosis) 05/2020 - 02/2012

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2003
14	SteroidsIBA 01/2018 - 10/2004
11	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2015 - 06/2002
11	Messenger RNA (mRNA)IBA 07/2015 - 01/2002
8	CytokinesIBA 01/2016 - 02/2002
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 01/2002
8	EWS-FLI fusion proteinIBA 07/2012 - 04/2003
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 04/2009
7	ParaffinIBA 01/2018 - 09/2002
7	Formaldehyde (Formol)FDA Link 01/2018 - 09/2002
6	Ifosfamide FDA LinkGeneric 11/2022 - 04/2009
6	Transcription Factors (Transcription Factor)IBA 01/2016 - 11/2004
6	Indicators and Reagents (Reagents)IBA 06/2015 - 10/2003
6	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 04/2002
6	beta CateninIBA 12/2008 - 01/2002
5	Methotrexate (Mexate)FDA LinkGeneric 07/2017 - 08/2010
5	Polyethylene (Polythene)IBA 01/2016 - 07/2010
5	LipidsIBA 11/2009 - 10/2004
5	Histone Deacetylase InhibitorsIBA 05/2008 - 04/2003
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2008 - 02/2003
5	Cadherins (E-Cadherin)IBA 01/2007 - 09/2003
4	AntigensIBA 01/2018 - 07/2015
4	tocilizumab (atlizumab)FDA Link 03/2014 - 08/2010
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2007 - 01/2002
3	Docetaxel (Taxotere)FDA Link 11/2022 - 08/2014
3	Gemcitabine FDA Link 11/2022 - 08/2014
3	Denosumab FDA Link 06/2021 - 08/2018
3	RNA (Ribonucleic Acid)IBA 02/2020 - 10/2019
3	Adalimumab (Humira)FDA Link 01/2017 - 11/2013
3	CAM 5.2 antigenIBA 10/2016 - 04/2009
3	MicroRNAs (MicroRNA)IBA 10/2016 - 03/2013
3	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 04/2016 - 01/2016
3	TitaniumIBA 02/2016 - 11/2013
3	Peptide Initiation Factors (Initiation Factor)IBA 05/2014 - 03/2012
3	Diphosphonates (Bisphosphonates)IBA 04/2014 - 06/2003
3	Collagen Type I (Type I Collagen)IBA 11/2013 - 06/2007
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012 - 07/2006
3	Tumor Suppressor Protein p14ARF (p14ARF)IBA 06/2011 - 08/2004
3	SYT-SSX fusion proteinIBA 02/2008 - 05/2004
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2007 - 01/2002
3	multidrug resistance-associated protein 1IBA 01/2006 - 02/2003
2	pazopanib FDA Link 10/2021 - 01/2017

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 11/2022 - 01/2002
24	Osteotomy 05/2017 - 11/2006
20	Therapeutics 06/2021 - 01/2002
12	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2017 - 01/2003
9	Hip Replacement Arthroplasty (Total Hip Replacement) 10/2016 - 10/2006
7	Radiotherapy 01/2022 - 10/2003
5	Transplantation 08/2015 - 11/2005
4	Prostheses and Implants (Prosthesis) 09/2020 - 07/2010
4	Curettage 04/2019 - 07/2010
4	Arthroplasty 01/2018 - 07/2010
4	Conservative Treatment 11/2016 - 09/2009
3	Surgical Amputation (Amputations) 01/2021 - 02/2007
3	Immunotherapy 09/2017 - 07/2015
3	Decompression 04/2012 - 08/2002
3	Neoadjuvant Therapy 12/2009 - 07/2008
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 09/2008 - 01/2002
2	Limb Salvage 09/2020 - 02/2007